Shalby Limited (NSE:SHALBY)

India flag India · Delayed Price · Currency is INR
185.92
-0.39 (-0.21%)
Jul 4, 2025, 10:30 AM IST
-31.51%
Market Cap 20.03B
Revenue (ttm) 10.87B
Net Income (ttm) 62.22M
Shares Out 107.49M
EPS (ttm) 0.64
PE Ratio 291.89
Forward PE n/a
Dividend 1.20 (0.65%)
Ex-Dividend Date Sep 19, 2024
Volume 17,525
Average Volume 145,208
Open 186.99
Previous Close 186.31
Day's Range 185.11 - 187.37
52-Week Range 177.25 - 325.00
Beta 0.45
RSI 52.04
Earnings Date Aug 1, 2025

About Shalby

Shalby Limited engages in the operation of multi-specialty hospitals primarily in India, the United States, Japan, Indonesia, Oman, the United Arab Emirates, Bangladesh, Nepal, and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers arthroscopy, arthroplasty, cardiology, vascular surgery, cardiothoracic and cardiac rehabilitation, cosmetic and aesthetic, dental cosmetic and implantology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroente... [Read more]

Sector Healthcare
Founded 1994
Employees 2,853
Stock Exchange National Stock Exchange of India
Ticker Symbol SHALBY
Full Company Profile

Financial Performance

In 2024, Shalby's revenue was 10.87 billion, an increase of 16.41% compared to the previous year's 9.34 billion. Earnings were 62.22 million, a decrease of -92.60%.

Financial Statements

News

Q3 2025 Shalby Ltd Earnings Call Transcript

Q3 2025 Shalby Ltd Earnings Call Transcript

5 months ago - GuruFocus

Shalby shares drop 4% as EBITDA falls 20.1% YoY in Q3

Shalby Ltd. saw a 4% decline in its stock price following the release of its Q3 results. AS of 10:53 AM, the shares were trading 4.57% lower at Rs 208.81. The company reported a revenue growth of 27.6...

5 months ago - Business Upturn

Shalby shares jump 3% after FDA approval for Duraniom knee replacement device

Shalby’s stock jumped 3% following the announcement that its U.S. subsidiary, Shalby Advanced Technologies (SAT) Inc., received FDA 510(k) Premarket Notification Clearance for its Duraniom™ knee repla...

6 months ago - Business Upturn

Monogram Technologies announces strategic collaboration with Shalby Limited

Monogram Technologies partners with Shalby Limited for multicenter clinical trial on mBȏs TKA System.

11 months ago - Seeking Alpha